The NIH Is Studying Ivermectin To Treat Covid-19 But Warns People Not To Use Animal Medicine

Huxley NIH Ivermectinjpg
The National Institutes of Health is currently studying the effectiveness of Ivermectin in treating COVID-19.
 Ivermectin Study | Research is currently being conducted in Cairo, Egypt. The NIH reports "as Egypt suffered a lot during the pandemic of COVID 19 with limited drug choices, many of the patients could not achieve viral clearance with the standard module of care the idea of introduction of new medications in the treatment protocol of COVID 19 management. Ivermectin had shown promising results in vitro studies and in limited in vivo studies. This clinical trial may open a new hope for COVID 19 patients as a new and cheap line of treatment".

Human doses of Ivermectin are Not the same as those prescribed for animal use, and the FDA strongly discourages people from ingesting these "highly concentrated" versions. "Such high doses can be highly toxic in humans."  FDA Warning

According to the FDA, "Ivermectin tablets are approved by the FDA to treat people with intestinal strongyloidiasis and onchocerciasis, two conditions caused by parasitic worms." The CDC reports "When used as prescribed for approved indications, it is generally safe and well tolerated."